Green Cross Holdings Corp 2024 SR
The report highlights GC Group's commitment to becoming a global healthcare leader through its 2024 sustainability initiatives. Key achievements include GC Biopharma obtaining US FDA approval for its plasma-derived product ALYGLO and commencing construction of Indonesia's first plasma fractionation plant. The company also advanced its R&D pipeline in rare diseases and cell therapies, with GC Cell receiving US FDA IND approval for a lupus nephritis treatment. Environmental efforts were marked by a 3% reduction in greenhouse gas emissions and the signing of a first-of-its-kind Power Purchase Agreement in the pharmaceutical industry. Socially, the group focused on nurturing bio-talents and expanding healthcare access globally.
Company: Green Cross Holdings Corp
Sector: Health Care
Country: South Korea
Year: 2024
Type: SR
Pages: 151
Green Cross Holdings Corp
Sustainability Report
The report highlights GC Group's commitment to becoming a global healthcare leader through its 2024 sustainability initiatives. Key achievements include GC Biopharma obtaining US FDA approval for its plasma-derived product ALYGLO and commencing construction of Indonesia's first plasma fractionation plant. The company also advanced its R&D pipeline in rare diseases and cell therapies, with GC Cell receiving US FDA IND approval for a lupus nephritis treatment. Environmental efforts were marked by a 3% reduction in greenhouse gas emissions and the signing of a first-of-its-kind Power Purchase Agreement in the pharmaceutical industry. Socially, the group focused on nurturing bio-talents and expanding healthcare access globally.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Net Zero Target
Employees